Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
917.8500 11.65 (1.29%)
NSE Jul 16, 2025 15:50 PM
Volume: 794.1K
 

logo
Strides Pharma Science Ltd.
edited 03 Mar 2020
917.85
1.29%
Strides Consumer to focus on differentiated products to crack OTC business
Strides Consumer to focus on differentiated products to crack OTC business
Moneycontrol
Consumer healthcare sector in India is valued at $3 billion and expected to witness a twofold growth by 2024, said Subodh Marwah, CEO, Strides Consumer.
Strides Pharma Science Ltd. is trading above all available SMAs
Strides receives USFDA approval for tetracycline hydrochloride capsules
Business Line | 04 Mar 2020 1 more
More from Strides Pharma Science Ltd.
Recommended
Market closes flat, ITC Hotels' Q1FY26 net profit beats Forecaster estimates by 35.5%
Trendlyne Marketwatch | 16 Jul 2025, 03:59PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
Earnings Call Transcript - Q1FY21 for Strides Pharma Science
| 05 Aug 2020